AQST
Aquestive Therapeutics IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$523.13M
P/E Ratio
—
EPS
$-0.61
Beta
1.45
52W High
$7.55
52W Low
$2.93
50-Day MA
$4.14
200-Day MA
$4.88
Dividend Yield
—
Profit Margin
-137.10%
Forward P/E
—
PEG Ratio
—
About Aquestive Therapeutics Inc
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and internationally. The company is headquartered in Warren, New Jersey.
Fundamentals
| Revenue (TTM) | $50.27M |
| Gross Profit (TTM) | $31.90M |
| EBITDA | $-55.34M |
| Operating Margin | -29.10% |
| Return on Equity | 0.00% |
| Return on Assets | -28.70% |
| Revenue/Share (TTM) | $0.44 |
| Book Value | $-0.27 |
| Price-to-Book | 14.15 |
| Price-to-Sales (TTM) | 10.41 |
| EV/Revenue | 9.07 |
| EV/EBITDA | -1.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 65.70% |
| Shares Outstanding | $125.45M |
| Float | $114.54M |
| % Insiders | 3.10% |
| % Institutions | 60.58% |
Historical Volatility
HV 10-Day
46.36%
HV 20-Day
57.44%
HV 30-Day
64.05%
HV 60-Day
51.64%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($8.89 target)
2
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026